| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 29 |
| 1 | ORAL SEMAGLUTIDE | 28 |
| 2 | LIRAGLUTIDE | 17 |
| 3 | ERGOCALCIFEROL | 10 |
| 4 | OLANZAPINE | 10 |
| 5 | ARIPIPRAZOLE | 8 |
| 6 | FUROSEMIDE | 7 |
| 7 | QUETIAPINE | 7 |
| 8 | CLONAZEPAM | 6 |
| 9 | LEVOTHYROXINE SODIUM | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFINACONAZOLE | 5 | 0.0025 |
| 1 | METHYLPHENIDATE HCL | 1 | 0.0008 |
| 2 | CAPLACIZUMAB | 1 | 0.0006 |
| 3 | OMAVELOXOLONE | 1 | 0.0006 |
| 4 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 5 | FLIBANSERIN | 1 | 0.0005 |
| 6 | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | 4 | 0.0005 |
| 7 | GARLIC | 2 | 0.0005 |
| 8 | ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR | 5 | 0.0004 |
| 9 | ORAL SEMAGLUTIDE | 28 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 2 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 3 | GLP-1 Receptor Agonist [EPC] | 82 | 0.0002 |
| 4 | beta3-Adrenergic Agonist [EPC] | 6 | 0.0001 |
| 5 | Vitamin K [EPC] | 1 | 0.0001 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 7 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 8 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 9 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |